BGT-INAD

N/A

Report date: 2026/03/17 20:00:15
First In Class

Base Information

Drug NameBGT-INAD
Drug Alias Nameadeno-associated viral vector serotype 9 containing the human PLA2G6 geneBGT-INAD
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionPLAP modulators
TargetsPLAP
Therapy Area/IndicationsNeuroaxonal Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBloomsbury Genetic Therapies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBloomsbury Genetic Therapies LtdUniversity College London
Inactive CompaniesN/A
Active IndicationsNeuroaxonal Dystrophies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A